STRASS 2 clinical trial receives MRFF funding - Cooper Rice-Brading Foundation
EORTC 1809 Strass II Trial Receives Strong Support from Anticancer Fund
Retroperitoneal Sarcoma: a STRASS II Q&A 2023 - EORTC Cancer Research Fund
Soft tissue sarcoma (Retroperitoneal Sarcoma)
Current Oncology | Free Full-Text | Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation
SARCOMA CONNECT on Twitter: "https://t.co/WXMOZSR4zK ⚡#Sarcoma . Comparison of #STRASS and #STREXIT data published in @AnnalsofSurgery :preoperative RT associated with better ARFS in patients with #liposarcoma. #MedED #oncology" / Twitter
Flow chart of the STRASS RCT and the 3-year extension study - ppt download
Alessandro Gronchi on Twitter: "@SprakerMDPhD @ASTRO_org @TARPSWG In addition unfortunately #STRASS didn't show any LC benefit, save for the liposarcoma subgroup. And for G1-2 only. Stay tuned... #STREXIT study results (pts treated off trial by ...
Current Oncology | Free Full-Text | The Landscape of Immunotherapy for Retroperitoneal Sarcoma
SARCOMA CONNECT on Twitter: "https://t.co/WXMOZSR4zK ⚡#Sarcoma . Comparison of #STRASS and #STREXIT data published in @AnnalsofSurgery :preoperative RT associated with better ARFS in patients with #liposarcoma. #MedED #oncology" / Twitter
Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward
Sarcoma UK supports EORTC's STRASS 2 clinical trial 2023 - EORTC Cancer Research Fund
EORTC 1809 STRASS II Trial In Retroperitoneal Sarcoma Receives Support By The Anticancer Fund 2023 - EORTC
PDF) Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: Results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ...
Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward
Soft Tissue & Bone Sarcoma Group - EORTC Cancer Research Fund
Australia and New Zealand Sarcoma Association - Our second Sarcoma Awareness Month webinar is next Thursday! Join Associate Professor David Gyorki as he shines a light on the STRASS 2 research being
Treatment Guidelines for Pre-operative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel EH Baldini, - ppt download
A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2) | SpringerLink
A trial looking at radiotherapy and surgery for retroperitoneal sarcoma ( STRASS) | Cancer Research UK
Cancers | Free Full-Text | Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward
Raising awareness for Sarcoma 2023 - EORTC Cancer Research Fund
First patient in EORTC-trial for retroperitoneal sarcoma
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group | SpringerLink
